Humanigen Inc (fka HGENQ)

[cowtown jay]

"WHO recommends prioritising XBB variants in development of new COVID shots"

https://www.hindustantimes.com/world-news/who-recommends-focusing-on-xbb-variants-in-development-of-new-covid-vaccine-101684425394196.html

The FDA's vaccine advisory panel is expected to follow suit today.

"June 12 (Reuters) - The U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday that updated COVID-19 vaccine boosters should target XBB subvariants for the 2023-2024 vaccination campaign.

The COVID vaccination campaign should feature a monovalent vaccine targeting either the XBB.1.5, XBB.1.16, or XBB.2.3, the staff reviewers said, ahead of a meeting of the FDA's panel of independent experts on Thursday."

https://www.nasdaq.com/articles/updated-covid-vaccines-need-to-target-xbb-subvariants-u.s.-fda-staff

No consideration is given to do what Humanigen has done, to produce a variant-agnostic treatment.

Focus is on perpetuating an annual revenue stream for Big Pharma, since it is not likely that small cap biotechs can afford to develop a new vaccine every year.

Humanigen's lenz, and especially if they collaborate with Novavax, can turn the revenue spigot off for the Big Pharma vaccines.

(I hate using this little text box to compose a message).